Loading…

Disclaimer

Tidy Storm Portal (License No. 1611639) is for educational and informational purposes only. Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs.

You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.

Please read our Financial Services Guide before deciding whether to obtain financial services from us.

Overview Tools X-Ray Watchlist

Vertex Pharmaceuticals Inc Fair Value | GoodMoat

Vertex Pharmaceuticals Inc (VRTX)

Vertex Pharmaceuticals Inc — Fair Value

VRTX · NASDAQ · Healthcare

$451.59-2.36%

GoodMoat Target

$344.45Caution-23.7% margin of safety

“At nearly 29 times earnings, Vertex's valuation demands exceptional scrutiny of its drug pipeline durability to justify such a premium over conservative investment principles.”

— In the voice of Graham

What is the Fair Value?

Estimate fair value using the Graham Number, earnings-based model, and PEG-adjusted valuation. Three independent methods averaged together.

Key Metrics

Market Cap

$114.58B

P/E Ratio

28.98

Forward P/E

—

EPS

$15.46

PEG Ratio

0.88

Book Value

$73.00

Dividend Yield

—

Profit Margin

32.94%

ROE

21.18%

Fair Value — Interactive Calculator

Free account • No credit card required

Use the interactive fair value with pre-loaded data for Vertex Pharmaceuticals Inc. Adjust discount rates, growth assumptions, and projection horizons to model different scenarios.

Pre-loaded inputs for VRTX:

EPS: $15.46

P/E: 28.98

Book Value: $73.00

Shares Out: 0.26B

52-Week Range

$366.54

$512.52

More Tools for VRTX

DCF Calculator Reverse DCF Company Overview Growth Projection Historical Performance YTD Return

Company Info

SectorHealthcare

IndustryBiotechnology

ExchangeNASDAQ